Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Community-Acquired Infections | 36 | 2023 | 463 | 6.030 |
Why?
|
Pneumonia | 33 | 2023 | 2102 | 4.210 |
Why?
|
Anti-Bacterial Agents | 69 | 2021 | 7136 | 3.930 |
Why?
|
Respiratory Tract Infections | 23 | 2016 | 956 | 2.650 |
Why?
|
Bacteremia | 11 | 2012 | 957 | 2.070 |
Why?
|
Pneumonia, Pneumococcal | 10 | 2019 | 126 | 1.950 |
Why?
|
Pneumonia, Bacterial | 8 | 2019 | 316 | 1.900 |
Why?
|
Drug Resistance, Bacterial | 16 | 2020 | 1031 | 1.500 |
Why?
|
Streptococcus pneumoniae | 15 | 2012 | 714 | 1.440 |
Why?
|
Bronchitis | 5 | 2013 | 201 | 1.410 |
Why?
|
Pneumococcal Infections | 9 | 2012 | 497 | 1.360 |
Why?
|
Inappropriate Prescribing | 5 | 2016 | 199 | 1.290 |
Why?
|
Hospitalization | 21 | 2021 | 10208 | 1.180 |
Why?
|
Macrolides | 7 | 2019 | 198 | 1.070 |
Why?
|
Pneumococcal Vaccines | 5 | 2011 | 391 | 1.050 |
Why?
|
Emergency Service, Hospital | 21 | 2020 | 7626 | 1.020 |
Why?
|
Primary Health Care | 12 | 2021 | 4537 | 1.010 |
Why?
|
Fluoroquinolones | 11 | 2017 | 306 | 0.960 |
Why?
|
Pennsylvania | 15 | 2017 | 615 | 0.950 |
Why?
|
Medical Errors | 5 | 2020 | 1291 | 0.850 |
Why?
|
Bed Occupancy | 2 | 2011 | 41 | 0.800 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 554 | 0.760 |
Why?
|
Angina Pectoris | 2 | 2021 | 976 | 0.710 |
Why?
|
Ambulatory Care | 14 | 2019 | 2711 | 0.700 |
Why?
|
Philadelphia | 12 | 2017 | 262 | 0.690 |
Why?
|
Drug Utilization | 8 | 2013 | 1181 | 0.680 |
Why?
|
Drug Prescriptions | 8 | 2015 | 1637 | 0.670 |
Why?
|
Length of Stay | 9 | 2020 | 6295 | 0.650 |
Why?
|
Humans | 217 | 2023 | 739398 | 0.650 |
Why?
|
Warfarin | 9 | 2010 | 1484 | 0.640 |
Why?
|
Digoxin | 3 | 2009 | 251 | 0.630 |
Why?
|
Physician Executives | 1 | 2018 | 128 | 0.620 |
Why?
|
Patient Discharge | 9 | 2020 | 3286 | 0.620 |
Why?
|
Urinary Tract Infections | 4 | 2017 | 766 | 0.620 |
Why?
|
Buprenorphine | 3 | 2020 | 634 | 0.610 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2016 | 976 | 0.610 |
Why?
|
Influenza, Human | 6 | 2019 | 1476 | 0.610 |
Why?
|
Prescription Drugs | 3 | 2009 | 594 | 0.610 |
Why?
|
Insurance Claim Review | 2 | 2019 | 720 | 0.600 |
Why?
|
Blood | 2 | 2011 | 597 | 0.590 |
Why?
|
Case Management | 2 | 2019 | 287 | 0.590 |
Why?
|
Family Characteristics | 3 | 2021 | 997 | 0.590 |
Why?
|
Electronic Health Records | 7 | 2021 | 4426 | 0.580 |
Why?
|
United States | 58 | 2021 | 69573 | 0.570 |
Why?
|
Anti-Infective Agents | 7 | 2014 | 973 | 0.570 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 677 | 0.570 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2019 | 941 | 0.570 |
Why?
|
Adverse Drug Reaction Reporting Systems | 3 | 2009 | 474 | 0.570 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 500 | 0.560 |
Why?
|
Acute Disease | 15 | 2020 | 7128 | 0.560 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2010 | 279 | 0.560 |
Why?
|
Patient Education as Topic | 9 | 2016 | 2275 | 0.550 |
Why?
|
Comprehension | 2 | 2014 | 607 | 0.540 |
Why?
|
Escherichia coli Infections | 8 | 2017 | 529 | 0.540 |
Why?
|
International Classification of Diseases | 4 | 2017 | 867 | 0.530 |
Why?
|
Adult | 95 | 2021 | 213394 | 0.530 |
Why?
|
Cough | 4 | 2019 | 552 | 0.520 |
Why?
|
Pharyngitis | 3 | 2016 | 214 | 0.520 |
Why?
|
Quality Assurance, Health Care | 6 | 2018 | 2213 | 0.520 |
Why?
|
Male | 131 | 2021 | 349022 | 0.520 |
Why?
|
Health Resources | 2 | 2011 | 920 | 0.510 |
Why?
|
Continuity of Patient Care | 4 | 2015 | 1054 | 0.510 |
Why?
|
Female | 133 | 2021 | 378853 | 0.500 |
Why?
|
Pneumonia, Viral | 4 | 2021 | 3248 | 0.500 |
Why?
|
Substance-Related Disorders | 3 | 2020 | 4239 | 0.500 |
Why?
|
Medication Errors | 5 | 2012 | 797 | 0.500 |
Why?
|
Patient Readmission | 10 | 2019 | 3106 | 0.490 |
Why?
|
Medication Adherence | 6 | 2015 | 2047 | 0.480 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.480 |
Why?
|
Communicable Disease Control | 1 | 2021 | 853 | 0.470 |
Why?
|
Streptococcus pyogenes | 2 | 2013 | 289 | 0.470 |
Why?
|
Glucocorticoids | 1 | 2023 | 2100 | 0.470 |
Why?
|
Patient Participation | 3 | 2020 | 1441 | 0.460 |
Why?
|
Otitis Media | 3 | 2012 | 276 | 0.460 |
Why?
|
Appointments and Schedules | 3 | 2020 | 415 | 0.460 |
Why?
|
Middle Aged | 90 | 2021 | 212863 | 0.450 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2017 | 525 | 0.450 |
Why?
|
Aged | 79 | 2021 | 162698 | 0.450 |
Why?
|
Managed Care Programs | 1 | 2018 | 949 | 0.440 |
Why?
|
Health Status | 5 | 2017 | 4013 | 0.440 |
Why?
|
Self Disclosure | 2 | 2005 | 251 | 0.440 |
Why?
|
Hospitals, Pediatric | 5 | 2016 | 1744 | 0.440 |
Why?
|
Adolescent | 57 | 2020 | 85405 | 0.430 |
Why?
|
Biota | 1 | 2012 | 22 | 0.430 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2017 | 694 | 0.430 |
Why?
|
Drug Utilization Review | 3 | 2012 | 245 | 0.420 |
Why?
|
Escherichia coli | 10 | 2017 | 4220 | 0.420 |
Why?
|
Streptococcal Infections | 3 | 2013 | 635 | 0.410 |
Why?
|
Physician-Patient Relations | 3 | 2020 | 3217 | 0.410 |
Why?
|
Phenytoin | 3 | 2009 | 198 | 0.410 |
Why?
|
beta-Lactams | 4 | 2019 | 155 | 0.410 |
Why?
|
Patient-Centered Care | 3 | 2019 | 1435 | 0.390 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3021 | 0.390 |
Why?
|
Insurance, Health | 3 | 2019 | 2491 | 0.390 |
Why?
|
Inpatients | 6 | 2020 | 2478 | 0.390 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3382 | 0.390 |
Why?
|
Quality of Health Care | 6 | 2015 | 4365 | 0.390 |
Why?
|
Cross-Sectional Studies | 27 | 2021 | 24714 | 0.380 |
Why?
|
Child, Preschool | 32 | 2021 | 40802 | 0.380 |
Why?
|
Medical Staff, Hospital | 2 | 2018 | 601 | 0.380 |
Why?
|
Population Surveillance | 6 | 2012 | 2629 | 0.380 |
Why?
|
Adrenal Cortex Hormones | 4 | 2021 | 1833 | 0.370 |
Why?
|
Cohort Studies | 31 | 2021 | 40389 | 0.370 |
Why?
|
Family Practice | 3 | 2016 | 516 | 0.370 |
Why?
|
Health Personnel | 4 | 2020 | 3203 | 0.370 |
Why?
|
Outpatients | 8 | 2019 | 1469 | 0.370 |
Why?
|
Staphylococcal Infections | 6 | 2017 | 1403 | 0.370 |
Why?
|
Information Services | 1 | 2011 | 244 | 0.370 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 428 | 0.360 |
Why?
|
Decision Support Techniques | 3 | 2020 | 1957 | 0.360 |
Why?
|
Self Administration | 2 | 2008 | 386 | 0.360 |
Why?
|
Probability | 4 | 2020 | 2500 | 0.360 |
Why?
|
Catheter-Related Infections | 1 | 2013 | 253 | 0.360 |
Why?
|
Defibrillators, Implantable | 2 | 2017 | 1441 | 0.350 |
Why?
|
Societies | 2 | 2020 | 105 | 0.350 |
Why?
|
Thoracostomy | 1 | 2010 | 72 | 0.350 |
Why?
|
Legionnaires' Disease | 1 | 2009 | 48 | 0.350 |
Why?
|
Retrospective Studies | 43 | 2020 | 76631 | 0.350 |
Why?
|
Drug Resistance, Microbial | 6 | 2014 | 860 | 0.350 |
Why?
|
Legionella pneumophila | 1 | 2009 | 46 | 0.340 |
Why?
|
Patient Care Team | 2 | 2020 | 2527 | 0.340 |
Why?
|
Chest Tubes | 1 | 2010 | 149 | 0.340 |
Why?
|
Hospitals, Veterans | 3 | 2009 | 404 | 0.340 |
Why?
|
Penicillins | 2 | 2004 | 384 | 0.340 |
Why?
|
Risk Assessment | 12 | 2021 | 23294 | 0.340 |
Why?
|
Respiratory System | 1 | 2012 | 553 | 0.330 |
Why?
|
Veterans Health | 1 | 2010 | 216 | 0.330 |
Why?
|
Carrier State | 4 | 2017 | 518 | 0.330 |
Why?
|
Calcitonin | 1 | 2010 | 336 | 0.320 |
Why?
|
Self Medication | 1 | 2008 | 117 | 0.320 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 2059 | 0.320 |
Why?
|
Attitude of Health Personnel | 7 | 2016 | 3844 | 0.320 |
Why?
|
Vaccines, Conjugate | 2 | 2010 | 332 | 0.320 |
Why?
|
Practice Guidelines as Topic | 11 | 2020 | 7274 | 0.320 |
Why?
|
Cross Infection | 2 | 2019 | 1414 | 0.310 |
Why?
|
Patient Transfer | 3 | 2019 | 763 | 0.310 |
Why?
|
Steroids | 1 | 2013 | 925 | 0.300 |
Why?
|
Crowding | 2 | 2012 | 145 | 0.300 |
Why?
|
Risk Factors | 34 | 2021 | 71974 | 0.300 |
Why?
|
Interviews as Topic | 6 | 2018 | 2533 | 0.290 |
Why?
|
Medical Records | 3 | 2013 | 1413 | 0.290 |
Why?
|
Databases, Factual | 6 | 2020 | 7690 | 0.290 |
Why?
|
Aged, 80 and over | 32 | 2021 | 57650 | 0.290 |
Why?
|
Infant | 23 | 2017 | 34923 | 0.290 |
Why?
|
Mental Recall | 3 | 2008 | 1201 | 0.280 |
Why?
|
Health Care Costs | 2 | 2019 | 3226 | 0.280 |
Why?
|
Preventive Health Services | 1 | 2011 | 576 | 0.280 |
Why?
|
Social Support | 5 | 2016 | 2112 | 0.280 |
Why?
|
Catheterization, Central Venous | 2 | 2008 | 513 | 0.280 |
Why?
|
Cognition | 2 | 2020 | 6686 | 0.280 |
Why?
|
Universities | 1 | 2011 | 946 | 0.270 |
Why?
|
Bacteria | 3 | 2012 | 2106 | 0.270 |
Why?
|
Feces | 4 | 2010 | 1389 | 0.270 |
Why?
|
Prevalence | 13 | 2021 | 15153 | 0.270 |
Why?
|
Self Report | 1 | 2017 | 3524 | 0.270 |
Why?
|
Microbial Sensitivity Tests | 10 | 2017 | 1866 | 0.270 |
Why?
|
Medicare | 6 | 2019 | 6497 | 0.270 |
Why?
|
Decision Support Systems, Clinical | 2 | 2013 | 1162 | 0.270 |
Why?
|
Physician Incentive Plans | 1 | 2007 | 161 | 0.270 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 535 | 0.260 |
Why?
|
Protein Precursors | 1 | 2010 | 1154 | 0.260 |
Why?
|
Periodontal Diseases | 1 | 2009 | 444 | 0.260 |
Why?
|
Cardiology | 1 | 2016 | 1654 | 0.260 |
Why?
|
Poisson Distribution | 3 | 2013 | 516 | 0.260 |
Why?
|
Substance Abuse, Intravenous | 2 | 2014 | 523 | 0.260 |
Why?
|
Pleural Effusion | 1 | 2008 | 337 | 0.260 |
Why?
|
Young Adult | 31 | 2020 | 56255 | 0.260 |
Why?
|
Home Nursing | 1 | 2005 | 92 | 0.250 |
Why?
|
Residence Characteristics | 3 | 2012 | 2041 | 0.250 |
Why?
|
Malpractice | 2 | 2020 | 568 | 0.250 |
Why?
|
HIV Infections | 14 | 2017 | 16764 | 0.250 |
Why?
|
Patient Compliance | 7 | 2016 | 2679 | 0.250 |
Why?
|
Prospective Studies | 26 | 2018 | 53037 | 0.250 |
Why?
|
Inservice Training | 1 | 2007 | 391 | 0.250 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 368 | 0.240 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6416 | 0.240 |
Why?
|
Soft Tissue Infections | 2 | 2016 | 156 | 0.240 |
Why?
|
Digestive System | 1 | 2005 | 251 | 0.240 |
Why?
|
Legislation, Drug | 1 | 2006 | 206 | 0.240 |
Why?
|
Safety | 1 | 2008 | 1186 | 0.230 |
Why?
|
Linguistics | 1 | 2003 | 96 | 0.230 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 2003 | 27 | 0.230 |
Why?
|
Age Distribution | 6 | 2017 | 2904 | 0.220 |
Why?
|
Time Factors | 18 | 2018 | 40050 | 0.220 |
Why?
|
Socioeconomic Factors | 8 | 2020 | 7726 | 0.220 |
Why?
|
Antibiotic Prophylaxis | 1 | 2008 | 631 | 0.220 |
Why?
|
Insurance, Liability | 2 | 2020 | 102 | 0.220 |
Why?
|
Child | 29 | 2021 | 77033 | 0.220 |
Why?
|
Premature Birth | 2 | 2012 | 1702 | 0.220 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15036 | 0.220 |
Why?
|
Pregnancy Outcome | 2 | 2012 | 2789 | 0.220 |
Why?
|
Logistic Models | 17 | 2019 | 13402 | 0.210 |
Why?
|
Sensitivity and Specificity | 7 | 2020 | 14740 | 0.210 |
Why?
|
Vaccination | 3 | 2015 | 3232 | 0.210 |
Why?
|
Sex Distribution | 5 | 2017 | 2296 | 0.210 |
Why?
|
Cultural Characteristics | 1 | 2003 | 261 | 0.210 |
Why?
|
Physicians | 3 | 2016 | 4539 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.210 |
Why?
|
Clinical Competence | 2 | 2016 | 4671 | 0.210 |
Why?
|
Viral Load | 4 | 2015 | 3299 | 0.210 |
Why?
|
Students | 1 | 2011 | 1637 | 0.200 |
Why?
|
Health Care Surveys | 6 | 2016 | 2448 | 0.200 |
Why?
|
Ambulatory Care Facilities | 4 | 2015 | 928 | 0.200 |
Why?
|
Pharmacy | 1 | 2003 | 89 | 0.200 |
Why?
|
Reimbursement, Incentive | 1 | 2006 | 537 | 0.190 |
Why?
|
Hospital Administration | 2 | 2017 | 354 | 0.190 |
Why?
|
Communication | 3 | 2016 | 3722 | 0.190 |
Why?
|
Internet | 2 | 2020 | 3048 | 0.190 |
Why?
|
Multivariate Analysis | 11 | 2020 | 12237 | 0.190 |
Why?
|
Drug Design | 1 | 2006 | 1088 | 0.180 |
Why?
|
Moraxellaceae Infections | 1 | 2019 | 8 | 0.180 |
Why?
|
Treatment Outcome | 18 | 2019 | 62693 | 0.180 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 44 | 0.180 |
Why?
|
Legionellosis | 1 | 2019 | 11 | 0.180 |
Why?
|
Chlamydophila Infections | 1 | 2019 | 23 | 0.180 |
Why?
|
Rectum | 1 | 2005 | 900 | 0.180 |
Why?
|
Hemorrhage | 2 | 2010 | 3441 | 0.180 |
Why?
|
Subacute Care | 2 | 2019 | 168 | 0.180 |
Why?
|
Haemophilus Infections | 1 | 2019 | 95 | 0.180 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2019 | 50 | 0.170 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2019 | 43 | 0.170 |
Why?
|
Incidence | 9 | 2019 | 20913 | 0.170 |
Why?
|
Evidence-Based Medicine | 3 | 2021 | 3606 | 0.170 |
Why?
|
Diagnosis | 1 | 2020 | 153 | 0.170 |
Why?
|
Opiate Substitution Treatment | 2 | 2020 | 399 | 0.170 |
Why?
|
Anti-HIV Agents | 4 | 2015 | 4320 | 0.170 |
Why?
|
Organizational Policy | 2 | 2016 | 428 | 0.170 |
Why?
|
Culture Techniques | 1 | 2019 | 557 | 0.170 |
Why?
|
Compensation and Redress | 1 | 2019 | 71 | 0.170 |
Why?
|
Heroin | 1 | 2019 | 117 | 0.170 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2006 | 1874 | 0.160 |
Why?
|
Otitis Media, Suppurative | 2 | 2016 | 26 | 0.160 |
Why?
|
Infection Control | 2 | 2021 | 968 | 0.160 |
Why?
|
Regional Health Planning | 1 | 2018 | 97 | 0.160 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3650 | 0.160 |
Why?
|
Odds Ratio | 8 | 2016 | 9846 | 0.160 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2009 | 563 | 0.160 |
Why?
|
Program Development | 2 | 2015 | 1313 | 0.160 |
Why?
|
Quality Indicators, Health Care | 3 | 2019 | 1828 | 0.150 |
Why?
|
Specialization | 1 | 2002 | 776 | 0.150 |
Why?
|
Case-Control Studies | 12 | 2020 | 21694 | 0.150 |
Why?
|
Dendritic Cells | 6 | 1992 | 2728 | 0.150 |
Why?
|
Sputum | 1 | 2019 | 474 | 0.150 |
Why?
|
Decision Making | 3 | 2021 | 3854 | 0.150 |
Why?
|
Postpartum Hemorrhage | 1 | 2021 | 259 | 0.150 |
Why?
|
Qualitative Research | 5 | 2016 | 2656 | 0.150 |
Why?
|
Pulmonary Medicine | 1 | 2019 | 213 | 0.150 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3752 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2019 | 1262 | 0.150 |
Why?
|
Health Expenditures | 1 | 2010 | 2348 | 0.150 |
Why?
|
Anticoagulants | 5 | 2010 | 4582 | 0.150 |
Why?
|
Disease Outbreaks | 2 | 2016 | 1779 | 0.140 |
Why?
|
Academic Medical Centers | 6 | 2018 | 2749 | 0.140 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15511 | 0.140 |
Why?
|
Fentanyl | 1 | 2019 | 412 | 0.140 |
Why?
|
Mupirocin | 1 | 2016 | 56 | 0.140 |
Why?
|
Comorbidity | 4 | 2021 | 10362 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 4 | 2015 | 2602 | 0.140 |
Why?
|
General Practice | 2 | 2016 | 99 | 0.140 |
Why?
|
Oncology Service, Hospital | 1 | 2016 | 57 | 0.140 |
Why?
|
International Normalized Ratio | 2 | 2008 | 365 | 0.140 |
Why?
|
Physical Examination | 2 | 2003 | 1231 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2020 | 3514 | 0.140 |
Why?
|
Age Factors | 6 | 2015 | 18349 | 0.130 |
Why?
|
Self Care | 3 | 2016 | 787 | 0.130 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2015 | 33 | 0.130 |
Why?
|
Deception | 1 | 2016 | 103 | 0.130 |
Why?
|
Reproducibility of Results | 6 | 2017 | 19811 | 0.130 |
Why?
|
Moral Obligations | 1 | 2016 | 98 | 0.130 |
Why?
|
Treatment Failure | 5 | 2017 | 2614 | 0.130 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2275 | 0.130 |
Why?
|
Maternal Health Services | 1 | 2021 | 452 | 0.130 |
Why?
|
DNA Topoisomerase IV | 3 | 2010 | 40 | 0.130 |
Why?
|
Confidence Intervals | 2 | 2012 | 2974 | 0.130 |
Why?
|
Catheters, Indwelling | 2 | 2008 | 422 | 0.130 |
Why?
|
Whooping Cough | 1 | 2015 | 85 | 0.130 |
Why?
|
Telephone | 3 | 2007 | 617 | 0.130 |
Why?
|
Chlorhexidine | 1 | 2016 | 161 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 919 | 0.130 |
Why?
|
Cluster Analysis | 3 | 2013 | 2711 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2009 | 2867 | 0.130 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2836 | 0.130 |
Why?
|
Nasal Cavity | 1 | 2017 | 306 | 0.130 |
Why?
|
Veterans | 2 | 2005 | 2505 | 0.120 |
Why?
|
Gram-Positive Bacteria | 2 | 2008 | 185 | 0.120 |
Why?
|
Regression Analysis | 4 | 2008 | 6452 | 0.120 |
Why?
|
Skin Diseases, Bacterial | 1 | 2015 | 66 | 0.120 |
Why?
|
DNA Gyrase | 3 | 2010 | 82 | 0.120 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 679 | 0.120 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5702 | 0.120 |
Why?
|
Aftercare | 1 | 2020 | 858 | 0.120 |
Why?
|
Medication Reconciliation | 1 | 2016 | 151 | 0.120 |
Why?
|
Certification | 1 | 2017 | 424 | 0.120 |
Why?
|
Sentinel Surveillance | 1 | 2016 | 291 | 0.120 |
Why?
|
Switzerland | 3 | 2020 | 249 | 0.120 |
Why?
|
Medicine | 1 | 2002 | 930 | 0.120 |
Why?
|
Computer-Assisted Instruction | 2 | 2011 | 363 | 0.120 |
Why?
|
Algorithms | 5 | 2020 | 13872 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1510 | 0.120 |
Why?
|
Massachusetts | 4 | 2021 | 8669 | 0.120 |
Why?
|
Anti-Infective Agents, Local | 1 | 2016 | 248 | 0.120 |
Why?
|
Narration | 1 | 2016 | 213 | 0.120 |
Why?
|
Sodium | 2 | 2017 | 1625 | 0.120 |
Why?
|
Antigens, Bacterial | 1 | 2019 | 1170 | 0.120 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6478 | 0.120 |
Why?
|
Hemoglobins | 2 | 2017 | 1529 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1735 | 0.110 |
Why?
|
Klebsiella Infections | 2 | 2005 | 136 | 0.110 |
Why?
|
Program Evaluation | 3 | 2021 | 2484 | 0.110 |
Why?
|
Small-Area Analysis | 1 | 2012 | 55 | 0.110 |
Why?
|
Internship and Residency | 4 | 2020 | 5761 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20676 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2015 | 392 | 0.110 |
Why?
|
Lymphocyte Cooperation | 2 | 1989 | 112 | 0.110 |
Why?
|
Klebsiella pneumoniae | 2 | 2005 | 244 | 0.110 |
Why?
|
Medicaid | 3 | 2014 | 2711 | 0.110 |
Why?
|
Anti-Retroviral Agents | 2 | 2012 | 1734 | 0.110 |
Why?
|
Occupational Diseases | 1 | 2020 | 1474 | 0.110 |
Why?
|
Bacterial Typing Techniques | 2 | 2010 | 256 | 0.100 |
Why?
|
Cesarean Section | 1 | 2021 | 1371 | 0.100 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1503 | 0.100 |
Why?
|
Smoking | 2 | 2012 | 8960 | 0.100 |
Why?
|
DNA, Bacterial | 3 | 2012 | 1467 | 0.100 |
Why?
|
Antigen-Presenting Cells | 4 | 1992 | 969 | 0.100 |
Why?
|
Antihypertensive Agents | 2 | 2017 | 2039 | 0.100 |
Why?
|
Efficiency, Organizational | 2 | 2007 | 694 | 0.100 |
Why?
|
Nose | 2 | 2017 | 499 | 0.100 |
Why?
|
Israel | 3 | 2020 | 794 | 0.100 |
Why?
|
Beds | 1 | 2011 | 48 | 0.100 |
Why?
|
Data Collection | 4 | 2008 | 3341 | 0.100 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 1989 | 517 | 0.100 |
Why?
|
Community Health Centers | 1 | 2015 | 428 | 0.100 |
Why?
|
Behavior, Addictive | 1 | 2017 | 460 | 0.100 |
Why?
|
Serotyping | 1 | 2011 | 339 | 0.100 |
Why?
|
Medically Uninsured | 2 | 2014 | 851 | 0.100 |
Why?
|
DNA, Ribosomal | 1 | 2012 | 288 | 0.100 |
Why?
|
Urine | 1 | 2013 | 370 | 0.100 |
Why?
|
Ambulances | 1 | 2011 | 95 | 0.100 |
Why?
|
Ethics, Medical | 1 | 2016 | 793 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2017 | 25470 | 0.100 |
Why?
|
Counseling | 1 | 2019 | 1526 | 0.100 |
Why?
|
Health Services Misuse | 2 | 2003 | 243 | 0.100 |
Why?
|
Hospital Bed Capacity | 1 | 2012 | 214 | 0.090 |
Why?
|
Hospitals, Urban | 2 | 2012 | 503 | 0.090 |
Why?
|
Time | 1 | 2012 | 528 | 0.090 |
Why?
|
Health Plan Implementation | 1 | 2013 | 351 | 0.090 |
Why?
|
Education | 1 | 2013 | 543 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2020 | 3609 | 0.090 |
Why?
|
Personality Tests | 1 | 2010 | 83 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2155 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8274 | 0.090 |
Why?
|
Physicians, Primary Care | 1 | 2016 | 577 | 0.090 |
Why?
|
Stroke | 3 | 2019 | 9898 | 0.090 |
Why?
|
Public Health | 2 | 2002 | 2587 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2015 | 736 | 0.090 |
Why?
|
Equipment Contamination | 2 | 2008 | 182 | 0.090 |
Why?
|
Attitude to Health | 2 | 2010 | 2047 | 0.090 |
Why?
|
Dermatology | 1 | 2019 | 871 | 0.090 |
Why?
|
Empyema, Pleural | 1 | 2010 | 62 | 0.090 |
Why?
|
Molecular Epidemiology | 1 | 2011 | 469 | 0.090 |
Why?
|
Emergencies | 1 | 2016 | 1152 | 0.090 |
Why?
|
Nasal Mucosa | 1 | 2012 | 372 | 0.090 |
Why?
|
Quality Improvement | 2 | 2015 | 3730 | 0.090 |
Why?
|
Delivery of Health Care | 3 | 2019 | 5272 | 0.090 |
Why?
|
Hospitals | 3 | 2019 | 3916 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4374 | 0.080 |
Why?
|
Biological Evolution | 1 | 2014 | 1072 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 946 | 0.080 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1449 | 0.080 |
Why?
|
Lymphokines | 2 | 1989 | 950 | 0.080 |
Why?
|
Critical Care | 2 | 2019 | 2624 | 0.080 |
Why?
|
Research | 2 | 2008 | 2001 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 257 | 0.080 |
Why?
|
Spleen | 3 | 1992 | 2359 | 0.080 |
Why?
|
France | 1 | 2009 | 516 | 0.080 |
Why?
|
Phylogeny | 2 | 2012 | 2789 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 7897 | 0.080 |
Why?
|
Anthrax | 1 | 2008 | 87 | 0.080 |
Why?
|
Drug Packaging | 1 | 2007 | 39 | 0.080 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2010 | 301 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2017 | 1780 | 0.080 |
Why?
|
Chronic Disease | 2 | 2020 | 9133 | 0.080 |
Why?
|
B-Lymphocytes | 3 | 1992 | 4663 | 0.080 |
Why?
|
Health Services Accessibility | 4 | 2009 | 5128 | 0.080 |
Why?
|
Databases as Topic | 1 | 2009 | 473 | 0.080 |
Why?
|
Forms and Records Control | 1 | 2008 | 160 | 0.070 |
Why?
|
Pulse | 1 | 2007 | 229 | 0.070 |
Why?
|
Acne Vulgaris | 1 | 2011 | 299 | 0.070 |
Why?
|
Amoxicillin | 1 | 2008 | 165 | 0.070 |
Why?
|
Fetal Death | 1 | 2009 | 446 | 0.070 |
Why?
|
Education, Medical, Continuing | 2 | 2004 | 840 | 0.070 |
Why?
|
Hepacivirus | 1 | 2014 | 1371 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2017 | 11668 | 0.070 |
Why?
|
Models, Economic | 1 | 2011 | 723 | 0.070 |
Why?
|
Bacteriological Techniques | 1 | 2008 | 277 | 0.070 |
Why?
|
AIDS Serodiagnosis | 1 | 2008 | 202 | 0.070 |
Why?
|
Medical History Taking | 2 | 2003 | 782 | 0.070 |
Why?
|
Prescriptions | 1 | 2009 | 383 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 327 | 0.070 |
Why?
|
Ofloxacin | 2 | 2006 | 65 | 0.070 |
Why?
|
Malaria | 1 | 2016 | 1234 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2018 | 38942 | 0.070 |
Why?
|
Genetic Variation | 2 | 2020 | 6539 | 0.070 |
Why?
|
Ciprofloxacin | 1 | 2008 | 313 | 0.070 |
Why?
|
Gram-Negative Bacteria | 1 | 2008 | 270 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1896 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 2971 | 0.070 |
Why?
|
Clindamycin | 2 | 2017 | 137 | 0.070 |
Why?
|
Bronchitis, Chronic | 2 | 2006 | 62 | 0.070 |
Why?
|
Integrins | 1 | 1990 | 845 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2373 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1778 | 0.070 |
Why?
|
Urban Population | 2 | 2015 | 2014 | 0.070 |
Why?
|
Social Perception | 1 | 2009 | 424 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 2009 | 570 | 0.060 |
Why?
|
Guideline Adherence | 2 | 2010 | 2261 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3510 | 0.060 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2005 | 103 | 0.060 |
Why?
|
Tachycardia | 1 | 2007 | 621 | 0.060 |
Why?
|
Feasibility Studies | 4 | 2018 | 5058 | 0.060 |
Why?
|
Epidemics | 1 | 2010 | 520 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2018 | 3246 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1364 | 0.060 |
Why?
|
Pilot Projects | 3 | 2017 | 8275 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12328 | 0.060 |
Why?
|
Medication Systems, Hospital | 1 | 2005 | 158 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2546 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1867 | 0.060 |
Why?
|
Insurance Coverage | 2 | 2015 | 1891 | 0.060 |
Why?
|
Caregivers | 1 | 2015 | 2067 | 0.060 |
Why?
|
Hepatitis C | 1 | 2014 | 1580 | 0.060 |
Why?
|
Focus Groups | 1 | 2008 | 1308 | 0.060 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 3 | 2010 | 144 | 0.060 |
Why?
|
Hospital Costs | 1 | 2010 | 982 | 0.060 |
Why?
|
Poverty | 2 | 2021 | 2626 | 0.060 |
Why?
|
Health Promotion | 1 | 2015 | 2187 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2008 | 788 | 0.060 |
Why?
|
Thromboembolism | 1 | 2009 | 984 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2015 | 3908 | 0.060 |
Why?
|
Risk-Taking | 1 | 2008 | 986 | 0.060 |
Why?
|
Infection Control Practitioners | 1 | 2002 | 12 | 0.050 |
Why?
|
Boston | 4 | 2020 | 9314 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2008 | 1186 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1139 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2004 | 194 | 0.050 |
Why?
|
Erythromycin | 1 | 2002 | 120 | 0.050 |
Why?
|
Morbidity | 2 | 2017 | 1763 | 0.050 |
Why?
|
Pregnancy | 3 | 2021 | 29002 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2018 | 2030 | 0.050 |
Why?
|
Uganda | 2 | 2017 | 1230 | 0.050 |
Why?
|
Leukocytes | 1 | 1990 | 2035 | 0.050 |
Why?
|
Genotype | 3 | 2011 | 12951 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2881 | 0.050 |
Why?
|
Hypertension | 2 | 2021 | 8431 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2007 | 961 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2913 | 0.050 |
Why?
|
Blood Coagulation | 1 | 2007 | 1122 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4791 | 0.050 |
Why?
|
Patient Admission | 2 | 2017 | 1383 | 0.050 |
Why?
|
Internal Medicine | 2 | 2019 | 996 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 1205 | 0.050 |
Why?
|
Respiration | 1 | 2007 | 1650 | 0.050 |
Why?
|
Communication Barriers | 1 | 2003 | 399 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 1162 | 0.050 |
Why?
|
Bacterial Infections | 2 | 2006 | 1391 | 0.050 |
Why?
|
Physicians, Family | 1 | 2002 | 346 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1175 | 0.050 |
Why?
|
Dentistry | 1 | 2020 | 113 | 0.040 |
Why?
|
Risk | 4 | 2019 | 9684 | 0.040 |
Why?
|
Hospitals, University | 2 | 2002 | 567 | 0.040 |
Why?
|
Pre-Eclampsia | 1 | 2009 | 1194 | 0.040 |
Why?
|
Fever | 1 | 2007 | 1607 | 0.040 |
Why?
|
Antigens | 3 | 1990 | 1462 | 0.040 |
Why?
|
HIV-1 | 2 | 2015 | 6931 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1904 | 0.040 |
Why?
|
Survival Rate | 2 | 2017 | 12761 | 0.040 |
Why?
|
International Cooperation | 1 | 2006 | 1420 | 0.040 |
Why?
|
Health Behavior | 2 | 2015 | 2624 | 0.040 |
Why?
|
Liability, Legal | 1 | 2020 | 212 | 0.040 |
Why?
|
Social Stigma | 2 | 2015 | 695 | 0.040 |
Why?
|
Health Services Research | 3 | 2015 | 1832 | 0.040 |
Why?
|
Saliva | 1 | 2003 | 805 | 0.040 |
Why?
|
Health Maintenance Organizations | 1 | 2001 | 644 | 0.040 |
Why?
|
Mice, Inbred Strains | 3 | 1990 | 1837 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2021 | 312 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2011 | 3866 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2008 | 1907 | 0.040 |
Why?
|
Biomedical Research | 1 | 2013 | 3301 | 0.040 |
Why?
|
Nova Scotia | 1 | 1997 | 34 | 0.040 |
Why?
|
China | 1 | 2003 | 2225 | 0.040 |
Why?
|
Drug Resistance | 1 | 2004 | 1610 | 0.040 |
Why?
|
Teaching Rounds | 1 | 2021 | 252 | 0.040 |
Why?
|
Surgery, Oral | 1 | 2020 | 146 | 0.040 |
Why?
|
Lacerations | 1 | 2019 | 144 | 0.040 |
Why?
|
T-Lymphocytes | 4 | 1990 | 10142 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 10398 | 0.040 |
Why?
|
Midwestern United States | 1 | 2017 | 70 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2003 | 744 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 1992 | 9259 | 0.040 |
Why?
|
Melatonin | 1 | 2003 | 719 | 0.040 |
Why?
|
Methicillin | 1 | 2017 | 61 | 0.040 |
Why?
|
Health Education | 1 | 2004 | 1054 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5462 | 0.040 |
Why?
|
Heart Failure | 2 | 2017 | 10793 | 0.040 |
Why?
|
Baltimore | 1 | 2016 | 230 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6237 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1675 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 547 | 0.030 |
Why?
|
Canada | 2 | 2016 | 2021 | 0.030 |
Why?
|
Staphylococcal Skin Infections | 1 | 2016 | 73 | 0.030 |
Why?
|
Prognosis | 4 | 2018 | 28901 | 0.030 |
Why?
|
Decision Trees | 1 | 1997 | 507 | 0.030 |
Why?
|
Climate | 1 | 2016 | 145 | 0.030 |
Why?
|
New England | 1 | 2018 | 1021 | 0.030 |
Why?
|
Antigens, Differentiation | 2 | 1989 | 925 | 0.030 |
Why?
|
Weather | 1 | 2016 | 228 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2016 | 445 | 0.030 |
Why?
|
Health Services Needs and Demand | 2 | 2014 | 1409 | 0.030 |
Why?
|
Longitudinal Studies | 4 | 2015 | 13880 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2015 | 108 | 0.030 |
Why?
|
Epidemiologic Factors | 1 | 2014 | 30 | 0.030 |
Why?
|
Gynecology | 1 | 2020 | 508 | 0.030 |
Why?
|
Hepatitis C Antibodies | 1 | 2014 | 145 | 0.030 |
Why?
|
Antigens, Surface | 2 | 1989 | 1667 | 0.030 |
Why?
|
Office Visits | 1 | 1998 | 600 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2002 | 1045 | 0.030 |
Why?
|
Models, Statistical | 2 | 2009 | 5113 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8307 | 0.030 |
Why?
|
Animals | 12 | 2019 | 168368 | 0.030 |
Why?
|
Patients | 1 | 2020 | 890 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 395 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1486 | 0.030 |
Why?
|
Nephrology | 1 | 2017 | 266 | 0.030 |
Why?
|
Obstetrics | 1 | 2020 | 660 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 630 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2019 | 1263 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9812 | 0.030 |
Why?
|
Prednisolone | 1 | 2014 | 332 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2277 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 466 | 0.030 |
Why?
|
Hospital Administrators | 1 | 2012 | 57 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2014 | 213 | 0.030 |
Why?
|
Hospitals, Teaching | 2 | 2009 | 1166 | 0.030 |
Why?
|
User-Computer Interface | 2 | 2011 | 1423 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1281 | 0.020 |
Why?
|
Lymphocyte Activation | 4 | 1990 | 5522 | 0.020 |
Why?
|
Conalbumin | 1 | 1990 | 5 | 0.020 |
Why?
|
Climate Change | 1 | 2016 | 411 | 0.020 |
Why?
|
Egg Proteins | 1 | 1990 | 58 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2005 | 4026 | 0.020 |
Why?
|
Dyspnea | 1 | 2018 | 1295 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2012 | 439 | 0.020 |
Why?
|
DNA Fingerprinting | 1 | 2010 | 112 | 0.020 |
Why?
|
Disclosure | 1 | 2016 | 735 | 0.020 |
Why?
|
Illness Behavior | 1 | 2010 | 22 | 0.020 |
Why?
|
Myoglobin | 1 | 1990 | 160 | 0.020 |
Why?
|
Medication Systems | 1 | 2010 | 31 | 0.020 |
Why?
|
Parents | 1 | 2004 | 3368 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2002 | 2530 | 0.020 |
Why?
|
Health Services | 1 | 2015 | 757 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2149 | 0.020 |
Why?
|
Administration, Topical | 1 | 2011 | 687 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2014 | 692 | 0.020 |
Why?
|
Mentors | 1 | 2015 | 632 | 0.020 |
Why?
|
Sinusitis | 2 | 2011 | 917 | 0.020 |
Why?
|
Immunoenzyme Techniques | 2 | 1990 | 1801 | 0.020 |
Why?
|
Health Policy | 1 | 2002 | 2655 | 0.020 |
Why?
|
Mutation, Missense | 2 | 2010 | 2552 | 0.020 |
Why?
|
Minor Lymphocyte Stimulatory Antigens | 1 | 1989 | 10 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1560 | 0.020 |
Why?
|
Hybridomas | 1 | 1990 | 452 | 0.020 |
Why?
|
Gram-Negative Aerobic Bacteria | 1 | 2008 | 8 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1989 | 370 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1990 | 517 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1206 | 0.020 |
Why?
|
Psychology | 1 | 2009 | 351 | 0.020 |
Why?
|
Self-Assessment | 1 | 2010 | 390 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 3029 | 0.020 |
Why?
|
Endocytosis | 2 | 1990 | 984 | 0.020 |
Why?
|
Quinine | 1 | 2007 | 54 | 0.020 |
Why?
|
Physician's Role | 1 | 2015 | 943 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1106 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2012 | 459 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1989 | 377 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1989 | 349 | 0.020 |
Why?
|
Benchmarking | 1 | 2014 | 1034 | 0.020 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1988 | 318 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 1990 | 935 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 1989 | 455 | 0.020 |
Why?
|
Immunoglobulins | 1 | 1990 | 881 | 0.020 |
Why?
|
Nalidixic Acid | 1 | 2006 | 19 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10945 | 0.020 |
Why?
|
Dexamethasone | 1 | 2014 | 1948 | 0.020 |
Why?
|
Cells, Cultured | 4 | 1990 | 19220 | 0.020 |
Why?
|
Mutation | 3 | 2007 | 29658 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2009 | 430 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 976 | 0.020 |
Why?
|
Radiography | 1 | 1997 | 6998 | 0.020 |
Why?
|
Cricetinae | 1 | 1990 | 2468 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 18125 | 0.020 |
Why?
|
Research Subjects | 1 | 2008 | 237 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1989 | 547 | 0.020 |
Why?
|
Pediatrics | 2 | 2016 | 3454 | 0.020 |
Why?
|
Mass Screening | 2 | 2014 | 5265 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6516 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1793 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1988 | 905 | 0.020 |
Why?
|
Leadership | 1 | 2015 | 1349 | 0.020 |
Why?
|
Solvents | 1 | 2006 | 301 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1988 | 1139 | 0.020 |
Why?
|
Education, Professional, Retraining | 1 | 2004 | 1 | 0.020 |
Why?
|
Data Display | 1 | 2005 | 184 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2017 | 3672 | 0.020 |
Why?
|
Belgium | 1 | 2004 | 103 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3739 | 0.010 |
Why?
|
Species Specificity | 1 | 1988 | 2480 | 0.010 |
Why?
|
Mice | 9 | 1992 | 81002 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 3909 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2907 | 0.010 |
Why?
|
Interleukins | 1 | 1988 | 788 | 0.010 |
Why?
|
Group Processes | 1 | 2005 | 225 | 0.010 |
Why?
|
Hygiene | 1 | 2004 | 98 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2010 | 1054 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8039 | 0.010 |
Why?
|
Travel | 1 | 2009 | 787 | 0.010 |
Why?
|
Flow Cytometry | 2 | 1990 | 5959 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1989 | 3137 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1997 | 12948 | 0.010 |
Why?
|
Asthma | 2 | 2014 | 5950 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3138 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3575 | 0.010 |
Why?
|
United States Department of Veterans Affairs | 1 | 2006 | 873 | 0.010 |
Why?
|
Antigens, Viral | 1 | 1985 | 1033 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1988 | 1883 | 0.010 |
Why?
|
Television | 1 | 2004 | 409 | 0.010 |
Why?
|
Pain | 1 | 2016 | 4923 | 0.010 |
Why?
|
Washington | 1 | 2001 | 314 | 0.010 |
Why?
|
Asia | 1 | 2002 | 604 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1162 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 1985 | 1038 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6174 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1989 | 2864 | 0.010 |
Why?
|
Phenotype | 2 | 2007 | 16301 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2564 | 0.010 |
Why?
|
Depression | 1 | 2018 | 7689 | 0.010 |
Why?
|
Lung | 1 | 1997 | 9782 | 0.010 |
Why?
|
North America | 1 | 2002 | 1249 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2002 | 640 | 0.010 |
Why?
|
DNA Repair | 1 | 2007 | 2030 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 12640 | 0.010 |
Why?
|
New York | 1 | 2000 | 888 | 0.010 |
Why?
|
Fluorouracil | 1 | 2002 | 1609 | 0.010 |
Why?
|
Colonic Polyps | 1 | 2002 | 543 | 0.010 |
Why?
|
Sepsis | 1 | 2011 | 2571 | 0.010 |
Why?
|
Cell Movement | 1 | 1989 | 5221 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3441 | 0.010 |
Why?
|
Europe | 1 | 2002 | 3331 | 0.010 |
Why?
|
Thymus Gland | 2 | 1992 | 1263 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7275 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15070 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 12985 | 0.010 |
Why?
|
Mental Health | 1 | 2008 | 2946 | 0.010 |
Why?
|
Colonoscopy | 1 | 2002 | 1363 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2002 | 6370 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2002 | 3453 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 1992 | 6397 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1989 | 7862 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1989 | 11460 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1992 | 647 | 0.010 |
Why?
|
Adenoma | 1 | 2002 | 2167 | 0.010 |
Why?
|
Pinocytosis | 1 | 1990 | 65 | 0.010 |
Why?
|
Organelles | 1 | 1992 | 270 | 0.010 |
Why?
|
Dermatitis, Contact | 1 | 1990 | 129 | 0.010 |
Why?
|
Half-Life | 1 | 1990 | 658 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1992 | 2665 | 0.010 |
Why?
|
Neoplasms | 1 | 2017 | 21507 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1992 | 1108 | 0.000 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1990 | 658 | 0.000 |
Why?
|
Peyer's Patches | 1 | 1988 | 122 | 0.000 |
Why?
|
Lymph Nodes | 2 | 1990 | 3454 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 2002 | 10961 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1988 | 829 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1988 | 1160 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1985 | 570 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1985 | 475 | 0.000 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 1985 | 149 | 0.000 |
Why?
|
Antibody Formation | 1 | 1990 | 1398 | 0.000 |
Why?
|
DNA Replication | 1 | 1990 | 1389 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2503 | 0.000 |
Why?
|
Burkitt Lymphoma | 1 | 1985 | 329 | 0.000 |
Why?
|
Kinetics | 1 | 1990 | 6475 | 0.000 |
Why?
|
Epitopes | 1 | 1988 | 2558 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1985 | 4319 | 0.000 |
Why?
|
DNA, Viral | 1 | 1985 | 2223 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1992 | 11347 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1990 | 4522 | 0.000 |
Why?
|
Viral Proteins | 1 | 1985 | 1900 | 0.000 |
Why?
|
Graft Rejection | 1 | 1990 | 4379 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1985 | 6610 | 0.000 |
Why?
|
Cell Survival | 1 | 1985 | 5877 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1985 | 3151 | 0.000 |
Why?
|
Rats | 1 | 1988 | 24270 | 0.000 |
Why?
|
Cell Line | 1 | 1985 | 15987 | 0.000 |
Why?
|